← Leaderboards
David Joseph Lefer
Louisiana State Univ Hsc Shreveport
$10,885,841
Attributed
$15,862,223
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,862,223 · 12
By mechanism
R01$14,592,027 · 9
R56$673,693 · 1
R43$300,000 · 1
R44$296,503 · 1
Top collaborators
- Ming Xian9 shared
- William A Coetzee4 shared
- Andrew Tinker4 shared
- Radhika Hiren Muzumdar1 shared
- Cathy A Swindlehurst1 shared
- Thomas Martin Vondriska1 shared
- Glenn Wilson1 shared
Most similar at Louisiana State Univ Hsc Shreveport
Same institution · by research overlap
- Lynn Harrison$3,188,042
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacMyocardial IschemiaReperfusion InjurySignaling MoleculeMyocardial InfarctionMediatingHeartMyocardialReperfusion TherapyMitochondriaPathway InteractionsIn VivoMyocardiumAcute Myocardial InfarctionSignal TransductionBiological ModelsCell DeathExhibitsMolecularHydrogen SulfideBiological AvailabilityHeart FailureFunctional DisorderPharmacology
Grant awards (40)
Hydrogen Sulfide and GLP-1 Combination Therapy to Treat HFpEF$759,206
R01 · FY2025 · HL · contact PI
Epigenetic Regulation of Heart Failure with Preserved Ejection Fraction$699,133
R01 · FY2025 · HL
Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic Injury$732,803
R01 · FY2023 · HL · contact PI
Hydrogen Sulfide Regulation in Cardioprotection$547,018
R01 · FY2023 · HL
Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic Injury$732,803
R01 · FY2022 · HL · contact PI
Hydrogen Sulfide Regulation in Cardioprotection$561,962
R01 · FY2022 · HL
Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic Injury$732,803
R01 · FY2021 · HL · contact PI
Hydrogen Sulfide Regulation in Cardioprotection$576,009
R01 · FY2021 · HL
Endogenous Hydrogen Sulfide Enzymes in Heart Failure$401,281
R01 · FY2021 · HL · contact PI
Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic Injury$756,303
R01 · FY2020 · HL · contact PI
Hydrogen Sulfide Regulation in Cardioprotection$607,369
R01 · FY2020 · HL
Endogenous Hydrogen Sulfide Enzymes in Heart Failure$401,281
R01 · FY2020 · HL · contact PI
Endogenous Hydrogen Sulfide Enzymes in Heart Failure$401,281
R01 · FY2019 · HL · contact PI
Cardioprotective Role of Humanin$673,693
R56 · FY2018 · HL
Novel Sulfide Releasing Agents for Ischemic Injury$446,622
R01 · FY2017 · HL
Novel Mitochondrial DNA Repair Enzyme for Heart Failure$296,503
R44 · FY2017 · HL
Novel Sulfide Releasing Agents for Ischemic Injury$450,250
R01 · FY2016 · HL
Novel antifibrotic small molecules for the treatment of heart failure$300,000
R43 · FY2016 · HL
Novel Sulfide Releasing Agents for Ischemic Injury$434,899
R01 · FY2015 · HL
Novel Sulfide Releasing Agents for Ischemic Injury$388,566
R01 · FY2014 · HL
Novel Sulfide Releasing Agents for Ischemic Injury$31,124
R01 · FY2014 · HL
Cardioprotective Actions of Hydrogen Sulfide$284,647
R01 · FY2013 · HL · contact PI
Cardioprotective Actions of Hydrogen Sulfide$80,564
R01 · FY2013 · HL · contact PI
Cardioprotective Actions of Hydrogen Sulfide$383,625
R01 · FY2012 · HL · contact PI
Nitrite Mediated Cardioprotection$254,237
R01 · FY2012 · HL · contact PI
Nitrite Mediated Cardioprotection$129,388
R01 · FY2012 · HL · contact PI
Cardioprotective Actions of Hydrogen Sulfide$387,500
R01 · FY2011 · HL · contact PI
Nitrite Mediated Cardioprotection$387,500
R01 · FY2011 · HL · contact PI
Nitrite Mediated Cardioprotection$387,500
R01 · FY2010 · HL · contact PI
Cardioprotective Actions of Hydrogen Sulfide$387,500
R01 · FY2010 · HL · contact PI
Nitrite Mediated Cardioprotection$387,500
R01 · FY2009 · HL · contact PI
Cardioprotective Actions of Hydrogen Sulfide$387,500
R01 · FY2009 · HL · contact PI
Mechanism of Myocardial Reperfusion Injury in Diabetes$181,423
R01 · FY2008 · HL · contact PI
Mechanism of Myocardial Reperfusion Injury in Diabetes$54,674
R01 · FY2008 · HL · contact PI
Mechanism of Myocardial Reperfusion Injury in Diabetes$236,097
R01 · FY2007 · HL · contact PI
Mechanism of Myocardial Reperfusion Injury in Diabetes$242,294
R01 · FY2006 · HL · contact PI
Mechanism of Myocardial Reperfusion Injury in Diabetes$217,500
R01 · FY2005 · HL
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES$184,285
R01 · FY2002 · HL
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES$180,586
R01 · FY2001 · HL
MECHANISMS OF MYOCARDIAL REPERFUSION INJURY--DIABETES$176,994
R01 · FY2000 · HL